TrialClinical interventions in aging2014

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.

Alan G Wade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.